Recruiting Peripheral T-Cell Lymphoma Studies in Tampa
Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
The main purpose of this study is to determine the effectiveness of the study drug pacritinib in people with relapsed or refractory lymphoproliferative disorders....
MB-105 in Patients With CD5 Positive T-cell Lymphoma
This is a single arm, two-stage, Phase 2, open-label, multicenter study of MB-105 in patients with CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r/r TCL). This study will apply a Simon tw...
About Peripheral T-Cell Lymphoma Clinical Trials in Tampa
Peripheral T-cell lymphomas are a diverse group of aggressive non-Hodgkin lymphomas that develop from mature T-cells. They account for about 10-15% of all NHL cases. Treatment includes combination chemotherapy, stem cell transplant, and newer targeted agents.
There are currently 2 peripheral t-cell lymphoma clinical trials recruiting participants in Tampa, FLORIDA. These studies are seeking a combined 146 participants. Research is being sponsored by University of Michigan Rogel Cancer Center, March Biosciences Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Peripheral T-Cell Lymphoma Clinical Trials in Tampa — FAQ
Are there peripheral t-cell lymphoma clinical trials in Tampa?
Yes, there are 2 peripheral t-cell lymphoma clinical trials currently recruiting in Tampa, FLORIDA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Tampa?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tampa research site will contact you about next steps.
Are clinical trials in Tampa free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tampa studies also compensate for your time and travel.
What peripheral t-cell lymphoma treatments are being tested?
The 2 active trials in Tampa are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral t-cell lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov